Circ_0016760 accelerates non‐small‐cell lung cancer progression through miR‐646/AKT3 signaling in vivo and in vitro
S Chen, L Zhou, R Ran, J Huang, Y Zheng… - Thoracic …, 2021 - Wiley Online Library
Background Currently, the prognosis of non‐small‐cell lung cancer (NSCLC) patients
remains dismal due to recurrence and metastasis. The purpose of our study was to explore …
remains dismal due to recurrence and metastasis. The purpose of our study was to explore …
[HTML][HTML] A comparison of mRNA and circRNA expression between squamous cell carcinoma and adenocarcinoma of the lungs
M Yu, Y Tian, M Wu, J Gao, Y Wang, F Liu… - … and Molecular Biology, 2020 - SciELO Brasil
Lung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD) are the two
major subtypes of non–small-cell lung cancer (NSCLC). This study aimed to compare mRNA …
major subtypes of non–small-cell lung cancer (NSCLC). This study aimed to compare mRNA …
Circular RNA expression profile in peripheral whole blood of lung adenocarcinoma by high: Throughput sequencing
Y Mu, F Xie, YF Huang, D Yang, G Xu, C Wang, Q Wu - Medicine, 2019 - journals.lww.com
Background: Lung adenocarcinoma (LA) is a most common form of non-small cell lung
cancer (NSCLC). To date, there are still no effective early diagnosis methods for patients to …
cancer (NSCLC). To date, there are still no effective early diagnosis methods for patients to …
CircRNA_102179 promotes the proliferation, migration and invasion in non-small cell lung cancer cells by regulating miR-330-5p/HMGB3 axis
Z Zhou, Z Wei, JC Yao, S Liu, F Wang, Z Wang… - … -Research and Practice, 2020 - Elsevier
Non-small cell lung cancer (NSCLC) accounting for 85% of all lung cancer was one of the
main causes of death worldwide. In this study, we investigated the role of circRNA_102179 …
main causes of death worldwide. In this study, we investigated the role of circRNA_102179 …
CircRNA_101237 promotes NSCLC progression via the miRNA-490-3p/MAPK1 axis
Z Zhang, X Gao, M Ma, C Zhao, Y Zhang, S Guo - Scientific reports, 2020 - nature.com
Non-small cell lung cancer (NSCLC) is a common type of lung cancer, characterized by a
poor prognosis. In the last several years, more and more studies have demonstrated the …
poor prognosis. In the last several years, more and more studies have demonstrated the …
Enhanced expression of circ_0000735 forecasts clinical severity in NSCLC and promotes cell progression via sponging miR-1179 and miR-1182
W Li, W Jiang, T Liu, J Lv, J Guan - Biochemical and biophysical research …, 2019 - Elsevier
Although numerous dysregulated circular RNAs (circRNAs) was discovered, the study
between circRNAs and non-small cell lung cancer (NSCLC) is just beginning. Here, we …
between circRNAs and non-small cell lung cancer (NSCLC) is just beginning. Here, we …
CircRNA has_circ_0017109 promotes lung tumor progression via activation of Wnt/β-catenin signaling due to modulating miR-671-5p/FZD4 axis
B Yang, B Zhang, Q Qi, C Wang - BMC Pulmonary Medicine, 2022 - Springer
Introduction Accumulating evidence highlights the critical roles of circular RNAs (circRNAs)
in the malignant progression of cancers. In this study, we investigated the expression pattern …
in the malignant progression of cancers. In this study, we investigated the expression pattern …
Hsa_circ_0010235 functions as an oncogenic drive in non-small cell lung cancer by modulating miR-433-3p/TIPRL axis
F Zhang, R Cheng, P Li, C Lu, G Zhang - Cancer Cell International, 2021 - Springer
Background Non-small cell lung cancer (NSCLC) is a threat to human health. Circular RNAs
(circRNAs) have been proved to function in NSCLC development. In this study, the role of …
(circRNAs) have been proved to function in NSCLC development. In this study, the role of …
Construction of a circular RNA–microRNA–messenger RNA regulatory network of hsa_circ_0043256 in lung cancer by integrated analysis
Y Li, R Shi, G Zhu, C Chen, H Huang, M Gao… - Thoracic …, 2022 - Wiley Online Library
Background Patients with non‐small cell lung cancer (NSCLC) are diagnosed in advanced
stages and with a poor 5‐year survival rate. There is a critical need to identify novel …
stages and with a poor 5‐year survival rate. There is a critical need to identify novel …
Activation of circ_0072088/miR‐1261/PIK3CA pathway accelerates lung adenocarcinoma progression
F Cao, S Liu, Z Li, L Meng, M Sang, B Shan - Thoracic Cancer, 2022 - Wiley Online Library
Abstract Background Circular RNAs (circRNAs) are involved in the tumorigenesis and
progression of lung adenocarcinoma (LUAD). This study aimed to determine the role of …
progression of lung adenocarcinoma (LUAD). This study aimed to determine the role of …